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This year, as in previous ones, microbiology was a frequent 
topic in the media’s scientific news. The journal Science chose 
the genome-editing method CRISPR (“clustered regularly in-
terspaced short palindromic repeat”) as the breakthrough of 
2015. The development of a genome-editing technique based 
on CRISPR is a turning point in genetic engineering, similar to 
PCR in the 1980s. Little known is the fact that it all started at 
the University of Alicante, around 1993, when Francisco J.M. 
Mojica, a microbiologist and SEM member, then a PhD stu-
dent, characterized what is now known as a CRISPR locus in 
the archaeum Haloferax 
mediterranii, which grows 
in nearby salterns. (Mojica 
coined the term CRISPR in 
2002, together with the 
Dutch researcher Ruud Jan-
sen, who was also working 
on this system). Mojica 
(Fig. 1) was studying the 
genetic modifications in-
duced by salt on specific re-
gions of the archaean ge-
nome; these mo difications 
altered the behavior of pro-
teins that cut DNA. One of 
those regions contained sev-
eral regularly spaced se-
quences. As those sequences 
were very abundant, Mojica assumed that they must play a sig-
nificant role, given that all of the archaean genome is generally 
useful for these microorganisms. He then learned that a Japa-
nese group had previously described those same sequences in a 
human intestinal bacterium. In the following years, the whole 
genome of many microorganisms was sequenced, and Mojica 
and his collaborators identified CRISPR sequences in many of 
them. After finding a phage fragment in one of the sequences, 
Mojica hypothesized that CRISPR was a type of adaptive im-
mune system for the cell. That assumption, which is now wide-
ly accepted, was initially met with skepticism by reviewers in 
1994. But, after refusals by several journals, Mojica’s paper 
was finally published in Molecular Microbiology [Mojica FJM, 
et al., Mol Microbiol 17:85-93 (1995)].
It soon became clear to Mojica that CRISPR was an inter-
ference system, although he did not know how it worked. In the 
meantime, many other scientists became interested on those 
sequences. In 2011, one of 
them, Virginijus Siksnys, 
from Vilnius University, 
Lithuania, cloned the 
CRISPR/Cas system from 
Streptococcus thermophi-
lus and expressed it in 
Escherichia coli, provid-
ing the latter with heterol-
ogous protection against 
plasmid transformation 
and phage infection. In 
2012, Jennifer Doudna, 
from the University of 
California-Berkeley, and 
Emmanuelle Charpentier, 
now at Umeå University 
in Sweden, and the Max 
Plank Institute for Infection Biology in Berlin, found that 
CRISPR sequences bound to Cas9, acts as a nuclease and cut 
specific DNA targets. Soon CRISPR/Cas9 was used to delete, 
suppress, add, or activate genes in various organisms, both pro-
karyotes and eukaryotes. Sadly though, while in 2015 Doudna 
and Charpentier were awarded one of the highest Spanish priz-
es for science, Mojica’s efforts went unrecognized. Indeed, “no 
Fig. 1. Francisco J.M. Mojica, in his lab at the University of Alicante. (Photograph 
from the University of Alicante website.)
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Table 1. Nobel Prizes in Physiology or Medicine related to microbiology or immunology
Year Scientists Work Field*
1901 Emil von Behring For his work on serum therapy, especially its application to diphtheria I
1902 Ronald Ross For his work on malaria, showing how the parasite enters its host P
1905 Robert Koch For his investigations and discoveries in relation to tuberculosis B
1907 Alphonse Laveran In recognition of his work on the role played by protozoa in causing diseases P
1908 Paul Ehrlich,
Ilya Mechnikov
In recognition of their work on immunity I
1919 Jules Bordet For his discoveries related to immunity I
1926 Johannes Fibiger For his discovery of Spiroptera carcinoma (a nematode) “causing cancer” (!) P
1927 Julius Wagner-Jauregg For his discovery of the therapeutic value of malaria inoculation in dementia paralytica P
1928 Charles Nicolle For his work on epidemic typhus B
1939 Gerhard Domagk For his discovery of the antibacterial effects of prontosil A
1945 Ernst B. Chain,
Alexander Fleming,
Howard Florey
For their development of penicillin and its curative effects on various infectious diseases A
1951 Max Theiler For his discoveries related to yellow fever and how to combat it V
1952 Selman A. Waksman For his discovery of streptomycin, the first antibiotic effective against tuberculosis A
1954 John F. Enders,
Frederick C. Robbins,
Thomas H. Weller
For their discovery of the ability of poliomyelitis viruses to grow in cultures of various types of 
cellular tissues 
V
1958 George Wells Beadle,
Lawrie Tatum,
Joshua Lederberg
For the discovery of genetic properties of bacteria, especially their ability for recombination B
1960 Frank Macfarlane Burnet,
Peter Medawar
For the discovery of the acquired immunological tolerance I
1966 Peyton Rous For his discovery of tumor-inducing viruses (work done in 1912!) V
1969 Max Delbrück,
Alfred D. Hershey,
Salvador E. Luria
For the discovery of the mechanisms of replication and genetic structure of viruses V
1972 Gerald M. Edelman,
Rodney R. Porter
For their discoveries concerning the chemical structure of antibodies I
1975 David Baltimore,
Renato Dulbecco,
Howard M. Temin
For their discoveries concerning the interaction between tumor viruses and the genetic material 
of the cell
V
1976 Baruch S. Blumberg,
D. Carleton Gajdusek
For their discoveries concerning new mechanisms for the origin and dissemination of infectious 
diseases
V-B-P
1997 Stanley B. Prusiner For his discovery of prions, a new biological agent of infection V
2005 Barry J. Marshall, 
J. Robin Warren
For their discovery of the bacterium Helicobacter pylori and its role in gastritis and peptic ulcer 
disease 
B
2008 Harld zur Hausen,
Françoise Barré-Sinoussi,
Luc Montagnier
For the discovery of papilloma virus and its relation to cancer cervix
For their discovery of the human immunodeficiency virus (HIV) 
V
2015 Willian C. Campbell,
Satoshi Omura,
Youyou Tu
For their discovery of a therapy against diseases caused by nematodes
For her discovery of a new (but coming from Chinese traditional medicine) treatment of malaria
A
Adapted from: The Nobel Foundation [nobelprize.org/medicine/laureates/index.html]
*Field (or related to): A, antibiotics/chemoterapics; B, bacteriology; I, immunology; P, parasitology and protistology; V, viruses and prions. (In some cases, 
the prize was shared with other persons working on fields not directly related to microbiology or immunology.)
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one is a prophet in his own land.” Now, with Nobel Prize 
watchers betting on the future likely winners, it is certain that 
sooner or later they will include the scientists who developed 
CRISPR/Cas9. Will be Mojica unrecognized again? Will he be 
as influential as Alexander Fleming, who was awarded the No-
bel Prize despite the fact that he did not work in the develop-
ment of penicillin as a powerful curative molecule? Neverthe-
less, the applications of this powerful gene-editing technique 
has raised important ethical questions, especially about its use 
in humans. As for Mojica, he continues to work on the CRISPR 
system and now leads a research project on immunization in 
bacteria and the adaptation of the CRISP-Cas I-E of Escherich-
ia coli and Salmonella enterica. 
Throughout the history of Nobel Prizes, roughly 25 have been 
directly related to microbiology or immunology (Table 1). The 
2015 Nobel Prize in Physiology or Medicine recognized dis-
coveries in the field of parasitic diseases. William C. Campbell, 
from Drew University, NJ, USA, and Satoshi Ōmura, from Ki-
tasato University, Tokyo, Japan, divided one half of the prize 
“for their discoveries concerning a novel therapy against infec-
tions caused by roundworm parasites.” The other half went to 
Youyou Tu, from the Academy of Traditional Chinese Medi-
cine, Beijing, China, “for her discoveries concerning a novel 
therapy against malaria” (Fig. 2).  
In December 1, 2015, the Pan American Health Organiza-
tion/World Health Organization (PAHO/WHO) released an 
epidemiological alert regarding the public health implications 
of zika virus infection and its possible relation with congenital 
anomalies, Guillain-Barré syndrome, and other neurological 
and autoimmune syndromes. The PAHO member states where the 
autochthonous circulation of zika virus has been confirmed are 
Brazil, Chile (Easter Island, in mid-Pacific), Colombia, El Salva-
dor, Guatemala, Mexico, Paraguay, Surinam, and Venezuela.
* * *
A basic knowledge of microbiology is crucial for citizens of all 
countries. The diffusion of this broad-ranging, important sub-
ject must be extended beyond the walls of schools and universi-
ties. With this objective in mind, museums can play an essential 
role in educating the public about microbes and their meaning 
for human life. However, until recently, microbes were for the 
most part ignored by museums, and, if they were ever men-
tioned, it was only as dreadful agents of terrible diseases able to 
decimate human populations. Their major role in the history of 
life and in present ecosystems was all but ignored. However, as 
John L. Ingraham wittily wrote [March of the Microbes, Har-
vard University Press, 2010]: “the percentage of disease-caus-
ing microorganism (pathogens) is far, far less than the percent-
age of humans that commit first-degree murder.” 
Maybe some day the presence of microorganisms in natural 
history museums will be as typical as now is the presence of 
animals or minerals. Fortunately, microbes have started to have 
the same recognition by museums that has long been granted to 
animals and minerals. Until recently, however, rarely were mi-
crobes shown in those museums in permanent exhibits. But that 
trend has made an inflection in the present decade and sveral 
museums have started to consider that microbes deserve their 
own spaces, and that their major role in the history of life and in 
Fig. 2. From the left to right: William C. Campbell, from Drew University, NJ, USA; Satoshi Ōmura, from Kitasato University, 
Tokyo, Japan; Youyou Tu, the Academy of Traditional Chinese Medicine, Beijing, China. (From The Nobel Foundation website 
[nobelprize.org/medicine/laureates/index.html].)
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the present ecosystems must be explained to visitors.
To our knowledge the first permanent exhibit to show the 
natural history (phylogeny and evolution, physiology, genet-
ics and ecology) and emphasize the non-pathological impor-
tance of microorganisms is at the Natural History Museum of 
Barcelona (MHNB, the Blue Museum), inaugurated on 27 
March, 2011. This exhibit is an essential part of the Planet 
Life section and offers visitors a comprehensive vision of the 
World of Microbes and their critical roles in the history of 
Earth and the biosphere. The MNHB occupies 9,000 m2 in an 
impressive building that architects Herzog & de Meuron 
made for the 2004 Barcelona’s Forum of Cultures. The new 
MHNB, which have a history of 135 years (!), have more than 
2 million specimens of rocks, minerals, fossils, plants and 
animals. Planet Life has pioneered the task of presenting a 
Gaian view of our planet’s tangled history, by revealing how 
rocks, plants, fungi, animals, and, indeed, microbes interact 
and modify each other in the Earth (Fig. 3).
In October 2014—and perhaps in keeping with the Neth-
erlands as the cradle of microbiology—an impressive micro-
bial “zoo,” named Micropia, was established in Amsterdam. 
Micropia is located next to the famous Artis Royal Zoo, one 
of the oldest zoos in Europe (Fig. 4). More recently, in No-
vember 2015, the New York City’s American Museum of 
Natural History inaugurated “The Secret World Inside You,” 
a temporary exhibit that will run until mid-August, 2016. The 
exhibit includes videos, 3-D models, interactive displays, and 
tutorial lectures taught by efficient and friendly university 
students in person. The “teacher” animates “pupils” to look 
at their own belly buttons, but not for a feeling of self-com-
placency but to investigate the microbes inhabiting there 
(Fig. 5). Finally, another project to bring microbes to muse-
ums was recently announced. Roberto Kolter (former presi-
dent of the American Society for Microbiology) and Scott 
Chimileski, a postdoctoral fellow in Kolter’s laboratory at the 
Harvard Medical School in Boston, are developing a project, 
with the support of the ASM, to exhibit the microbial world at 
the Harvard Museum of Natural History, an institution that 
attracts thousands of visitors each year.
Hopefully, all natural history museums will soon follow 
the example of Barcelona, Amsterdam, New York, and Cam-
bridge, MA (Harvard), and show the general public that life 
cannot be explained without taking into account the “Unseen 
World”—the tiniest living beings in nature—, and that the 
“macro-bios” (including ourselves) cannot live without the 
“micro-bios.”
 
* * *
Let’s talk about International Microbiology in 2015. But, 
first, some background considerations must be offered: To the 
vast number of already existing scientific journals in all fields, 
many others are added almost daily. These are often an-
nounced in unsolicited emails inviting us to submit articles 
and/or to join their editorial boards. The first thing that comes 
to mind is that we are in front of a business intention, which 
would not be reprehensible, because business is one of the 
aims of publishing companies. Currently, most science and 
humanities journals are in the hands of a few very large inter-
national publishing houses, which, in general, offer excellent 
products. However, scandals related to the intentions of more 
recent emerging publications should serve as a reminder that 
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Fig. 3. Planet Life, a permanent exhibit of the Natural History Museum of Barcelona (the Blue Museum), inaugurated in 2011, displays a comprehensive vision 
of the World of Microbes and the major role that microbes have played in the history of Earth and the biosphere. (Photographs by M. Berlanga.)
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these new journals should be carefully evaluated by researchers 
looking for a place to publish their work. The majority of ex-
perienced researchers have a list of benchmark journals that 
they rely on to stay current in their fields. Such lists offer a 
way to manage the enormous number of scholarly publica-
tions available in print and, especially, via the internet. But 
whether we, as researchers, can and do benefit from this huge 
amount of information is unclear, as is the impact on science 
of this plethora of highly specialized journals and their dilu-
tion of potentially important knowledge. Today the motto of 
“publish or perish” still holds true and researchers continue to 
produce manuscripts at a not always justifiable rate and num-
ber (“salami papers”, as they are whimsically called). Conse-
quently, the main objective of a scientific research paper—to 
communicate research results and discuss their significance 
with other experts—has become “secondary.”
Presently, the technical process of the scientific publica-
tion has experienced many changes, both in rapidity and qual-
ity, but the most important factor is the possibility of reaching 
the whole world via internet. The management and publica-
tion (both online and in print) of International Microbiol-
ogy is a complex task, depending on the efforts of a small 
Fig. 5. “The Secret World Inside You,” a temporal exhibit at the American Museum of 
Natural History of New York, inaugurated in December 2015. (Photographs by M. Berlanga.)
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Fig. 4. Micropia, a permanent large exibit of the world of microbes in  the Amsterdam zoo 
inaugurated in 2014. (Photographs from the museum website.)
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group of people working at one or more stages of the process. 
Although the printed journal has been overshadowed by the 
online version, there has been no change in our efforts, both 
from the scientific (content) and editorial (presentation) points 
of view, to publish good-quality manuscripts. The people re-
sponsible for the internal functioning of the journal meet reg-
ularly to discuss and decide the manuscript evaluation, edit-
ing, and preparation. The Publication Board consists of two 
Coeditors-in-Chief (located in Madrid and Barcelona), sever-
al Associate Editors, a General Secretary, a Managing Coordi-
nator, a Digital Media Coordinator, and a Webmaster. Their 
names as well as those of the Editorial Board members (na-
tional and international) appear on page p. 2 of each issue.
Manuscript management through ScholarOne system was 
initiated in 2013 for a term of 3 years (2013–2015). At the end 
of that period, the extremely high fees charged by that com-
pany for its services, together with the difficulty and cost of 
introducing the necessary adaptations led to our decision not 
to renew the contract for 2016. In addition, the system had the 
unwanted consequence that many manuscripts of very poor 
quality were submitted, most of which had to be rejected after 
the first general evaluation. At the other end, there was no in-
crease in the dissemination of the journal’s articles. Currently, 
authors can submit their manuscripts through our own web-
page [http://revistes.iec.cat/index.php/IM], hosted at the Insti-
tute for Catalan Studies, Barcelona, where the digital manage-
ment of the journal is efficiently administered. 
Journals that serve as the official publication of a scientific 
society, as is the case for International Microbiology and 
the Spanish Society for Microbiology (SEM), typically have 
very limited economic resources. These journals need the 
support of all members of the professional society. The SEM’s 
membership currently numbers about 1800, with members 
coming from Spain and elsewhere. SEM members are asked 
to support the journal via efforts to enhance its scientific level, 
by submitting good-quality manuscripts. The main objective 
of International Microbiology is to diffuse the unity and 
diversity of the microbiological sciences (In pluribus unum), 
But, although the journal publishes articles from all over the 
world, also try (we think successfully) to promote research in 
microbiology and the dissemination of the obtained knowl-
edge in Spain, Portugal, and Latin America. The quality of a 
journal and its international reputation reflect on the quality of 
the scientific society responsible for its publication. The team 
that has worked to produce the official SEM’s journal since 
1994 had little experience in science editing and publishing 
when they started. They “learned on the job,” through small 
and large successes as well as errors, but they have remained 
devoted in their efforts to achieve a product in which they and 
the SEM proudly stand behind. 
But all this is not sufficient. Publishing a scientific journal 
has an economic cost, and what cannot be covered with mon-
ey is made through the effort and personal commitment of a 
team. The effort, however, is worthy when the product gets 
recognition. Suffice it to mention that due to these efforts and 
the contributions of the authors whose work has been pub-
lished in the journal, the quality of International Microbi-
ology has been acknowledged by the FECYT (Spanish 
Foundation for Science and Technology) in the two calls to 
which we applied (2012 and 2015, calls are launched every 3 
years), consistently obtaining a score of 20 out of 20 criteria 
evaluated. But the most important recognition was the inclu-
sion of the journal in ISI-Current Contents, which came in 
2005 after being sought by the SEM since the early 1980s. In 
the following years, the journal was included in the major da-
tabases of international scientific journals, most importantly, 
PubMed and Scopus.
Each year, in the December issue we publish information 
on the manuscripts received, accepted, and rejected, their 
origin, indexes of the authors, titles, and keywords, and a 
list of the reviewers active during that year (see pp. 265–270 
in this issue). During 2015, 125 manuscripts were received 
through ScholarOne, with an additional 10 requested 
directly by the journal to experts (reviews, editorials, and 
perspectives). A total of 28 articles were published: 18 
from ScholarOne and 10 directly received via the webpage 
of the journal. Among all articles received by ScholarOne, 
107 were rejected. According to geographical origin, the 
published articles came from: Spain (12), the rest of Europe 
(5), Latin America (6), the USA (2), and Taiwan and Japan 
(3). International Microbiology staunchly try to explore 
and diffuses knowledge about microbiology. While it may 
not be as pervasive or as persistent as the microorganisms it 
covers, we do aspire to continue talking about them for as 
long as possible. To the SEM, its members, microbiologists 
in general, and friends, we, the members of the Publication 
Board, thank you for contributing to the continuity of the 
journal in the way that you best know how to and do: by 
submitting manuscripts that convey the quality and interest of 
your work and as devoted readers of the journal.
